Related references
Note: Only part of the references are listed.Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial
Raju Kapoor et al.
LANCET NEUROLOGY (2010)
Pediatric Multiple Sclerosis
Sunita Venkateswaran et al.
NEUROLOGIST (2010)
Ibudilast in relapsing-remitting multiple sclerosis A neuroprotectant?
F. Barkhof et al.
NEUROLOGY (2010)
Pro: Can biomarkers be gold standards in Alzheimer's disease?
Reisa Sperling et al.
ALZHEIMERS RESEARCH & THERAPY (2010)
Frontotemporal Dementia-amyotrophic Lateral Sclerosis Complex is Simulated by Neurodegeneration With Brain Iron Accumulation
Alexander Frizell Santillo et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2009)
Glatiramer acetate has no impact on disease progression in ALS at 40 mg/day: A double-blind, randomized, multicentre, placebo-controlled trial
Vincent Meininger et al.
AMYOTROPHIC LATERAL SCLEROSIS (2009)
In Vivo Morphological Changes in Animal Models of Amyotrophic Lateral Sclerosis and Alzheimer's-Like Disease: MRI Approach
Pavle R. Andjus et al.
ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2009)
Autoantibodies against beta-Amyloid Are Common in Alzheimer's Disease and Help Control Plaque Burden
Alexander Kellner et al.
ANNALS OF NEUROLOGY (2009)
Magnetic Resonance Imaging as a Potential Surrogate for Relapses in Multiple Sclerosis: A Meta-analytic Approach
Maria Pia Sormani et al.
ANNALS OF NEUROLOGY (2009)
MRI Measures of Alzheimer's Disease and the AddNeuroMed Study
Andrew Simmons et al.
BIOMARKERS IN BRAIN DISEASE (2009)
Autoantibodies to myelin basic protein (MBP) in healthy individuals and in patients with multiple sclerosis: a role in regulating cytokine responses to MBP
Chris J. Hedegaard et al.
IMMUNOLOGY (2009)
Characterizing Iron Deposition in Multiple Sclerosis Lesions Using Susceptibility Weighted Imaging
E. Mark Haacke et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2009)
Tau phosphorylation at threonine-175 leads to fibril formation and enhanced cell death: implications for amyotrophic lateral sclerosis with cognitive impairment
May Gohar et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Early structural changes in individuals at risk of familial Alzheimer's disease: a volumetry and magnetization transfer MR imaging study
A. Ginestroni et al.
JOURNAL OF NEUROLOGY (2009)
A longitudinal diffusion tensor MRI study of the cervical cord and brain in amyotrophic lateral sclerosis patients
F. Agosta et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)
Association of α-Synuclein Immunoreactivity With Inflammatory Activity in Multiple Sclerosis Lesions
Jian-Qiang Lu et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
Dysregulation of Iron Homeostasis in the CNS Contributes to Disease Progression in a Mouse Model of Amyotrophic Lateral Sclerosis
Suh Young Jeong et al.
JOURNAL OF NEUROSCIENCE (2009)
Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis
Bruce D. Trapp et al.
LANCET NEUROLOGY (2009)
Structural Findings in the Basal Ganglia in Genetically Determined and Idiopathic Parkinson's Disease
Kathrin Reetz et al.
MOVEMENT DISORDERS (2009)
A single-center, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis
X. Montalban et al.
MULTIPLE SCLEROSIS JOURNAL (2009)
Multi-parametric classification of Alzheimer's disease and mild cognitive impairment: The impact of quantitative magnetization transfer MR imaging
Claus Kiefer et al.
NEUROIMAGE (2009)
MRI as an outcome in multiple sclerosis clinical trials
M. Daumer et al.
NEUROLOGY (2009)
Whole brain-based computerized neuroimaging in ALS and other motor neuron disorders
Julian Grosskreutz et al.
AMYOTROPHIC LATERAL SCLEROSIS (2008)
Magnetization transfer ratio evolution with demyelination and remyelination in multiple sclerosis lesions
Jacqueline T. Chen et al.
ANNALS OF NEUROLOGY (2008)
Multiple sclerosis: An immune or neurodegenerative disorder?
Bruce D. Trapp et al.
ANNUAL REVIEW OF NEUROSCIENCE (2008)
Therapeutic attenuation of mitochondrial dysfunction and oxidative stress in neurotoxin models of Parkinson's disease
Edward C. Stack et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2008)
Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis
J. M. Anderson et al.
BRAIN (2008)
Central nervous system effects of current and emerging multiple sclerosis-directed immuno-therapies
Jack P. Antel et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2008)
The lipopolysaccharide Parkinson's disease animal model: mechanistic studies and drug discovery
Garima Dutta et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2008)
MRI Assessment of Basal Ganglia Iron Deposition in Parkinson's Disease
Lauren I. Wallis et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2008)
Grey matter pathology in multiple sclerosis
Jeroen J. G. Geurts et al.
LANCET NEUROLOGY (2008)
MRI in multiple sclerosis: current status and future prospects
Rohit Bakshi et al.
LANCET NEUROLOGY (2008)
Reduction of free radicals in multiple sclerosis:: effect of glatiramer acetate (Copaxone®)
C. Iarlori et al.
MULTIPLE SCLEROSIS (2008)
Longitudinal magnetic resonance spectroscopic imaging of primary progressive multiple sclerosis patients treated with glatiramer acetate: multicenter study
B. R. Sajja et al.
MULTIPLE SCLEROSIS JOURNAL (2008)
Tracking retinal nerve fiber layer loss after optic neuritis: a prospective study using optical coherence tomography
F. Costello et al.
MULTIPLE SCLEROSIS JOURNAL (2008)
Myelin water imaging of multiple sclerosis at 7 T: Correlations with histopathology
Cornelia Laule et al.
NEUROIMAGE (2008)
The immunology of multiple sclerosis
Amit Bar-Or
SEMINARS IN NEUROLOGY (2008)
Optical coherence tomography: a window into the mechanisms of multiple sclerosis
Elliot M. Frohman et al.
NATURE CLINICAL PRACTICE NEUROLOGY (2008)
Nature and functions of autoantibodies
Keith Elkon et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2008)
Lobar distribution of changes in gray matter and white matter in memory clinic patients: Detected using magnetization transfer imaging
A. C. G. M. van Es et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2007)
Persistent activation of microglia is associated with neuronal dysfunction of callosal projecting pathways and multiple sclerosis-like lesions in relapsing -: remitting experimental autoimmune encephalomyelitis
Stine Rasmussen et al.
BRAIN (2007)
Mechanism of action of glatiramer acetate in treatment of multiple sclerosis
Martin S. Weber et al.
NEUROTHERAPEUTICS (2007)
Myelin breakdown and iron changes in Huntington's disease: Pathogenesis and treatment implications
George Bartzokis et al.
NEUROCHEMICAL RESEARCH (2007)
Quantitative magnetization transfer imaging in Alzheimer disease
Basil H. Ridha et al.
RADIOLOGY (2007)
Cerebrospinal fluid total tau protein levels in patients with multiple sclerosis
M. Terzi et al.
ACTA NEUROLOGICA SCANDINAVICA (2007)
Autoantibodies to alpha-synuclein in inherited Parkinson's disease
Katerina K. Papachroni et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Mitochondrial dysfunction in Huntington's disease:: the bioenergetics of isolated and in situ mitochondria from transgenic mice
Jorge M. A. Oliveira et al.
JOURNAL OF NEUROCHEMISTRY (2007)
A magnetic resonance imaging study of patients with Parkinson's disease with mild cognitive impairment and dementia using voxel-based morphometry
Mona K. Beyer et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)
CD4+ T cells from Copolymer-1 immunized mice protect dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease
Chad Laurie et al.
JOURNAL OF NEUROIMMUNOLOGY (2007)
Magnetization transfer ratio in early period of Parkinson disease
Yonca Anik et al.
ACADEMIC RADIOLOGY (2007)
Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double-blind, placebo-controlled trial
Jerry S. Wolinsky et al.
ANNALS OF NEUROLOGY (2007)
The blood-brain-barrier in multiple sclerosis: Functional roles and therapeutic targeting
Jorge Correale et al.
AUTOIMMUNITY (2007)
Multiple sclerosis: a complicated picture of autoimmunity
Henry F. McFarland et al.
NATURE IMMUNOLOGY (2007)
TCH346 as a neuroprotective drug in Parkinsons disease: a double-blind, randomised, controlled trial
C. Warren Olanow et al.
LANCET NEUROLOGY (2006)
Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau
D. R. Williams
INTERNAL MEDICINE JOURNAL (2006)
The inflammatory NADPH oxidase enzyme modulates motor neuron degeneration in amyotrophic lateral sclerosis mice
Du-Chu Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Regional gray matter atrophy in early primary progressive multiple sclerosis - A voxel-based morphometry study
Jorge Sepulcre et al.
ARCHIVES OF NEUROLOGY (2006)
Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1
Oleg Butovsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Neurodegeneration and neuroprotection in multiple sclerosis and other neurodegenerative diseases
Suhayl Dhib-Jalbut et al.
JOURNAL OF NEUROIMMUNOLOGY (2006)
Cortical demyelination in multiple sclerosis: A substrate for cognitive deficits?
Alexandra Kutzelnigg et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)
Issues in neuroprotection clinical trials in Parkinson's disease
K Kieburtz
NEUROLOGY (2006)
Randomized controlled phase II trial of glatiramer acetate in ALS
PH Gordon et al.
NEUROLOGY (2006)
Immunopathogenesis and immunotherapy of multiple sclerosis
B Hemmer et al.
NATURE CLINICAL PRACTICE NEUROLOGY (2006)
Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients
R Dutta et al.
ANNALS OF NEUROLOGY (2006)
Age at disability milestones in multiple sclerosis
C Confavreux et al.
BRAIN (2006)
Natural history of multiple sclerosis: a unifying concept
C Confavreux et al.
BRAIN (2006)
Relation of quantitative indexes of concurrent α-synuclein abnormalities to clinical outcome in autopsy-proven Alzheimer disease
R Holtzer et al.
ARCHIVES OF NEUROLOGY (2006)
Increasing cord atrophy in early relapsing-remitting multiple sclerosis: a 3 year study
W Rashid et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2006)
Cortical demyelination and diffuse white matter injury in multiple sclerosis
A Kutzelnigg et al.
BRAIN (2005)
Aggregated α-synuclein activates microglia:: a process leading to disease progression in Parkinson's disease
W Zhang et al.
FASEB JOURNAL (2005)
Microglia and neuroprotection: implications for Alzheimer's disease
WJ Streit
BRAIN RESEARCH REVIEWS (2005)
Interferon beta promotes nerve growth factor secretion early in the course of multiple sclerosis
K Biernacki et al.
ARCHIVES OF NEUROLOGY (2005)
Microglia as potential contributors to motor neuron injury in amyotrophic lateral sclerosis
SA Sargsyan et al.
GLIA (2005)
Nasal vaccination with a proteosome-based adjuvant and glatiramer acetate clears beta-amyloid in a mouse model of Alzheimer disease
D Frenkel et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Multicentre, randomised, double blind, placebo controlled, phase III study of weekly, low dose, subcutaneous interferon beta-1a in secondary progressive multiple sclerosis
O Andersen et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2004)
Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging
T Eckert et al.
NEUROIMAGE (2004)
Molecular changes in neurons in multiple sclerosis:: Altered axonal expression of Nav1.2 and Nav1.6 sodium channels and Na+/Ca2+ exchanger
MJ Craner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Mitochondrial dysfunction and reactive oxygen species in excitotoxicity and apoptosis: Implications for the pathogenesis of neurodegenerative diseases
AC Rego et al.
NEUROCHEMICAL RESEARCH (2003)
Interferon-beta blocks infiltration of inflammatory cells and reduces infarct volume after ischemic stroke in the rat
TB Veldhuis et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2003)
Part II:: α-synuclein and its molecular pathophysiological role in neurodegenerative disease
KK Dev et al.
NEUROPHARMACOLOGY (2003)
The enigma of multiple sclerosis: inflammation and neurodegeneration cause heterogeneous dysfunction and damage
T Owens
CURRENT OPINION IN NEUROLOGY (2003)
Magnetization transfer changes of grey and white matter in Parkinson's disease
N Tambasco et al.
NEURORADIOLOGY (2003)
Interferon β-1a in primary progressive MS -: An exploratory, randomized, controlled trial
SM Leary et al.
NEUROLOGY (2003)
Inflammation in multiple sclerosis: the good, the bad, and the complex
G Martino et al.
LANCET NEUROLOGY (2002)
Eight-year follow-up study of brain atrophy in patients with MS
E Fisher et al.
NEUROLOGY (2002)
Diffuse axonal and tissue injury in patients with multiple sclerosis with low cerebral lesion load and no disability
N De Stefano et al.
ARCHIVES OF NEUROLOGY (2002)
Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis
DT Chard et al.
BRAIN (2002)
Benefit of interferon β-1a on MSFC progression in secondary progressive MS
JA Cohen et al.
NEUROLOGY (2002)
Final analysis of the European multicenter trial on IFNβ-1b in secondary-progressive MS
L Kappos et al.
NEUROLOGY (2001)
Glatiramer acetate reduces the proportion of new MS lesions evolving into black holes
M Filippi et al.
NEUROLOGY (2001)
Randomized controlled trial of interferon-beta-1a in secondary progressive MS - MRI results
DKB Li et al.
NEUROLOGY (2001)
Inflammation and Alzheimer's disease
H Akiyama et al.
NEUROBIOLOGY OF AGING (2000)
A randomized controlled trial of recombinant interferon beta-1a in ALS
E Beghi et al.
NEUROLOGY (2000)
Share Paper
